Neoadjuvant Immunotherapy for Liver Cancer: Shrinking Tumors, Growing Responses
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
Progress Against Cancer
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.